These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12820679)
1. Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. Magnoni S; Stocchetti N; Colombo G; Carlin A; Colombo A; Lipton JM; Catania A J Neurotrauma; 2003 Mar; 20(3):251-60. PubMed ID: 12820679 [TBL] [Abstract][Full Text] [Related]
2. Altered levels of α-melanocyte stimulating hormone in cerebrospinal fluid and plasma of patients with traumatic brain injury. Feng G; Feng J; Zhang S; Tong Y; Zhang Q; Yang X; Zhang H Brain Res; 2018 Oct; 1696():22-30. PubMed ID: 29859146 [TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Catania A; Cutuli M; Garofalo L; Airaghi L; Valenza F; Lipton JM; Gattinoni L Crit Care Med; 2000 May; 28(5):1403-7. PubMed ID: 10834686 [TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of alpha-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis. Airaghi L; Garofalo L; Cutuli MG; Delgado R; Carlin A; Demitri MT; Badalamenti S; Graziani G; Lipton JM; Catania A Nephrol Dial Transplant; 2000 Aug; 15(8):1212-6. PubMed ID: 10910447 [TBL] [Abstract][Full Text] [Related]
5. Biphasic elevation in cerebrospinal fluid and plasma concentrations of endothelin 1 after traumatic brain injury in human patients. Maier B; Lehnert M; Laurer HL; Marzi I Shock; 2007 Jun; 27(6):610-4. PubMed ID: 17505299 [TBL] [Abstract][Full Text] [Related]
6. Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Yamaoka-Tojo M; Tojo T; Shioi T; Masuda T; Inomata T; Izumi T Intern Med; 2006; 45(7):429-34. PubMed ID: 16679696 [TBL] [Abstract][Full Text] [Related]
7. Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Sviri GE; Soustiel JF; Zaaroor M Acta Neurochir (Wien); 2006 May; 148(5):529-33; discussion 533. PubMed ID: 16322908 [TBL] [Abstract][Full Text] [Related]
8. Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjects. Catania A; Suffredini AF; Lipton JM Neuroimmunomodulation; 1995; 2(5):258-62. PubMed ID: 8739198 [TBL] [Abstract][Full Text] [Related]
9. Alpha-melanocyte stimulating hormone in critically injured trauma patients. Todd SR; Kao LS; Catania A; Mercer DW; Adams SD; Moore FA J Trauma; 2009 Feb; 66(2):465-9. PubMed ID: 19204522 [TBL] [Abstract][Full Text] [Related]
10. The neuropeptide alpha-MSH in HIV infection and other disorders in humans. Catania A; Airaghi L; Garofalo L; Cutuli M; Lipton JM Ann N Y Acad Sci; 1998 May; 840():848-56. PubMed ID: 9629310 [TBL] [Abstract][Full Text] [Related]
11. Protective action of NDP-MSH in experimental subarachnoid hemorrhage. Gatti S; Lonati C; Acerbi F; Sordi A; Leonardi P; Carlin A; Gaini SM; Catania A Exp Neurol; 2012 Mar; 234(1):230-8. PubMed ID: 22230666 [TBL] [Abstract][Full Text] [Related]
12. Elevated concentrations of plasma alpha-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients. Airaghi L; Capra R; Pravettoni G; Maggiolo F; Suter F; Lipton JM; Catania A J Lab Clin Med; 1999 Mar; 133(3):309-15. PubMed ID: 10072263 [TBL] [Abstract][Full Text] [Related]
13. Effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic HLA-DR expression in patients with septic shock. Matejec R; Kayser F; Schmal F; Uhle F; Bödeker RH; Maxeiner H; Kolbe JA Peptides; 2013 Sep; 47():133-41. PubMed ID: 23891702 [TBL] [Abstract][Full Text] [Related]
14. Production and effects of alpha-melanocyte-stimulating hormone during acute lung injury. Colombo G; Gatti S; Sordi A; Turcatti F; Carlin A; Rossi C; Lonati C; Catania A Shock; 2007 Mar; 27(3):326-33. PubMed ID: 17304115 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. Robertson B; Dostal K; Daynes RA J Immunol; 1988 Jun; 140(12):4300-7. PubMed ID: 2836510 [TBL] [Abstract][Full Text] [Related]
16. Serum α-melanocyte-stimulating hormone may act as a protective biomarker for non-traumatic osteonecrosis of the femoral head. Mao Z; Liu G; Chen JJ; Liu D; Xu MP; Zhao C; Yang HT; Yue YB Ann Clin Biochem; 2018 Jul; 55(4):453-460. PubMed ID: 28990818 [TBL] [Abstract][Full Text] [Related]
17. Dynamic changes of α-melanocyte-stimulating hormone levels in the serum of patients with craniocerebral trauma. Du X; Dong B; Li C; Zhang F; Ji Y; Zhang J; Yin C Exp Ther Med; 2017 Sep; 14(3):2511-2516. PubMed ID: 28962188 [TBL] [Abstract][Full Text] [Related]
18. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury. Kleindienst A; Meissner S; Eyupoglu IY; Parsch H; Schmidt C; Buchfelder M Acta Neurochir Suppl; 2010; 106():247-50. PubMed ID: 19812958 [TBL] [Abstract][Full Text] [Related]
19. Changes in dopaminergic control of circulating melanocyte-stimulating hormone-related peptides at puberty. Facchinetti F; Bernasconi S; Iughetti L; Genazzani AD; Ghizzoni L; Genazzani AR Pediatr Res; 1995 Jul; 38(1):91-4. PubMed ID: 7478804 [TBL] [Abstract][Full Text] [Related]
20. Plasma alpha-melanocyte-stimulating hormone: sex differences and correlations with obesity. Donahoo WT; Hernandez TL; Costa JL; Jensen DR; Morris AM; Brennan MB; Hochgeschwender U; Eckel RH Metabolism; 2009 Jan; 58(1):16-21. PubMed ID: 19059526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]